Trial intelligence / Profile preview

Fractional CO2 Laser + Topical Tacrolimus vs Topical Tacrolimus Alone for Nail Psoriasis

NCT07919873Not yet recruiting

Sponsor
Cairo University
Start
Nov 2026
Primary completion
Feb 2027
01

Overview

Randomised, open-label trial in nail psoriasis (2 arms), sponsored by Cairo University. Primary endpoint: Target Nail Psoriasis Severity Index at 3 months. Planned start Nov 2026; status: not yet recruiting.

02

Conditions

nail psoriasis

Beyond the preview

Go deeper on NCT07919873.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07919873.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call